Immuno-Oncology
Dedicated to the
dynamic field of cancer
immunotherapy, this session will explore immune checkpoint blockade, cellular
therapies, and tumour microenvironment modulation. Experts will address the
latest mechanisms of immune escape and resistance, along with biomarkers for
therapy response prediction.
The session will
spotlight novel combination strategies aimed at enhancing anti-tumour
immunity and patient survival outcomes. Presentations will include updates on
clinical trials, translational research, and regulatory perspectives.
Interactive discussions will focus on challenges in integrating immunotherapy
into clinical practice.
Subtracks:
- Immune Checkpoint Blockade
- Tumour-Infiltrating Lymphocyte Therapy
- CAR-T and CAR-NK Therapies
- Immunotherapy Combination Strategies
- Immune-Related Adverse Events Management
- Cancer Vaccine Development